SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-004768
Filing Date
2022-02-16
Accepted
2022-02-16 14:23:00
Documents
79
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1864329
2 ex31-1.htm EX-31.1 12013
3 ex31-2.htm EX-31.2 11820
4 ex32-1.htm EX-32.1 6492
5 ex32-2.htm EX-32.2 6636
6 form10-q_001.jpg GRAPHIC 4151
  Complete submission text file 0001493152-22-004768.txt   8916795

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE taug-20211231.xsd EX-101.SCH 62316
8 XBRL CALCULATION FILE taug-20211231_cal.xml EX-101.CAL 69217
9 XBRL DEFINITION FILE taug-20211231_def.xml EX-101.DEF 250200
10 XBRL LABEL FILE taug-20211231_lab.xml EX-101.LAB 473229
11 XBRL PRESENTATION FILE taug-20211231_pre.xml EX-101.PRE 367884
73 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1737586
Mailing Address 4 NANCY COURT, SUITE 4 WAPPINGERS FALLS NY 12590
Business Address 4 NANCY COURT, SUITE 4 WAPPINGERS FALLS NY 12590 917-796-9926
TAURIGA SCIENCES, INC. (Filer) CIK: 0001142790 (see all company filings)

IRS No.: 651102237 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53723 | Film No.: 22643034
SIC: 2833 Medicinal Chemicals & Botanical Products